Patent strategy
for a borderless
world
We help European startups and US investors navigate the full complexity of American IP law — from patent prosecution to portfolio analysis — with the precision of scientists and the authority of seasoned attorneys.
The EP-to-US
gap is real
USPTO practices, CAFC rulings, and SCOTUS interpretations on novelty, utility, obviousness, and written description create invisible pitfalls for European filers. We bridge that gap with fluency in both systems and deep technical expertise in chemistry, biotech, diagnostics, and medical devices.
Two critical
audiences
- European startups in Chem, Biotech, Diagnostics & Medical Devices entering the US market
- US investors evaluating the IP strength of European companies before committing capital
- Inventors needing expert review of AI-generated patent applications before USPTO filing
- Companies requiring FTO analysis, infringement opinions, and patentability assessments
- Businesses negotiating IP contracts: licensing, collaborations, and joint ventures
Full-spectrum
IP services
From initial patent drafting to complex portfolio strategy, we provide the full scope of IP legal services your organization needs — delivered by attorneys who are also scientists, at rates that make sense for growing companies.
Your IP is only as strong as
the experts behind it.
Attorney with 20+ years of experience across all aspects of patent law, including FTO opinions, patent prosecution, ANDA litigation, and IPR proceedings. Deep technical expertise in organic chemistry, materials science, life sciences, and AI-enabled molecular design. Former in-house counsel at Vir Biotechnology, Vizgen, Conagen, and Nuclera/E Ink.
Bar: Massachusetts • Illinois • USPTO Registered
IP attorney and scientist with 20+ years of combined academic and legal experience. Former Associate Professor and NIH-funded principal investigator at Boston University, with over 75 peer-reviewed publications and four issued patents as inventor. In private practice, she has prosecuted patents across diagnostics, medical devices, antibody technologies, and nanoparticle formulations, most recently as in-house patent attorney at Invaio Sciences (a Flagship Pioneering company).
Bar: District of Columbia • USPTO Registered
AI writes.
Attorneys protect.
AI tools can generate patent application drafts at speed. But speed without scrutiny is risk. AI-generated claims may lack the precision, enablement, or written description requirements demanded by the USPTO — and a patent that fails examination is no protection at all.
We review, refine, and stand behind every application we file — regardless of how the first draft was created.
"The misconception is that human IP review is unnecessary for documents generated with AI. It's the opposite."
AI drafts require expert analysis of claim scope, enablement, and written description before filing. Our scientific backgrounds allow us to assess not just the legal language but the underlying science — something no AI tool can fully do on its own.
Let us assess
your portfolio.
Whether you are a European startup preparing for US market entry, or a US investor evaluating IP before committing capital, we are available for a direct, substantive conversation about your patent position.